Transcriptional responses in the adaptation to ischaemia-reperfusion injury: A study of the effect of ischaemic preconditioning in total knee arthroplasty patients

Journal of Translational Medicine

Volumn 8, Issue , 2010, Pages

  Murphy, Terence ^a,b   Walsh, Pauline M ^a   Doran, Peter P ^a   Mulhall, Kevin J ^a,b  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b CAPPAGH NATIONAL ORTHOPAEDIC HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; HEMOGLOBIN;

AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DNA MICROARRAY; DNA SEQUENCE; EARLY RESPONSE GENE; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; ISCHEMIC PRECONDITIONING; LEUKOCYTE COUNT; MALE; MICROARRAY ANALYSIS; MITOCHONDRIAL GENE; MUSCLE BIOPSY; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; TOTAL KNEE REPLACEMENT; UPREGULATION; VALIDATION PROCESS; ADAPTATION; BLOOD; DEMOGRAPHY; GENETIC TRANSCRIPTION; GENETICS; KNEE ARTHROPLASTY; METHODOLOGY; PATHOPHYSIOLOGY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTATION, PHYSIOLOGICAL; AGED; ARTHROPLASTY, REPLACEMENT, KNEE; DEMOGRAPHY; FEMALE; GENE EXPRESSION PROFILING; HUMANS; ISCHEMIC PRECONDITIONING; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REPERFUSION INJURY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION, GENETIC;

EID: 77951944143     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-8-46     Document Type: Article

References (32)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
2. Papanastasiou S, Estdale SE, Homer-Vanniasinkam S, Mathie RT. Protective effect of preconditioning and adenosine pretreatment in experimental skeletal muscle reperfusion injury. Br J Surg 1999, 86(7):916-922. 10.1046/j.1365-2168.1999.01164.x, 10417565.
3. Liu GS, Thornton J, Van Winkle DM, Stanley AW, Olsson RA, Downey JM. Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart. Circulation 1991, 84(1):350-356.
4. Jenkins DP, Pugsley WB, Alkhulaifi AM, Kemp M, Hooper J, Yellon DM. Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. Heart 1997, 77(4):314-318. 484723, 9155608.
5. Clavien PA, Selzner M, Rudiger HA, Graf R, Kadry Z, Rousson V, Jochum W. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003, 238(6):843-850. discussion 851-842., 10.1097/01.sla.0000098620.27623.7d, 1356166, 14631221.
6. Petrowsky H, McCormack L, Trujillo M, Selzner M, Jochum W, Clavien PA. A prospective, randomized, controlled trial comparing intermittent portal triad clamping versus ischemic preconditioning with continuous clamping for major liver resection. Ann Surg 2006, 244(6):921-928. discussion 928-930., 10.1097/01.sla.0000246834.07130.5d, 1856627, 17122617.
7. Yang Y, Chen SX, Zhang WX. [Effect of ischemic preconditioning on human lung cell apoptosis in vivo and the expression of regulating gene bcl-2]. Hunan Yi Ke Da Xue Xue Bao 2002, 27(1):43-45.
8. Teoh LK, Grant R, Hulf JA, Pugsley WB, Yellon DM. The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. Cardiovasc Res 2002, 53(1):175-180. 10.1016/S0008-6363(01)00435-7, 11744026.
9. Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995, 77(3):611-621.
10. Baines CP, Goto M, Downey JM. Oxygen radicals released during ischemic preconditioning contribute to cardioprotection in the rabbit myocardium. J Mol Cell Cardiol 1997, 29(1):207-216. 10.1006/jmcc.1996.0265, 9040035.
11. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994, 266(3 Pt 2):H1145-1152.
12. Tong H, Chen W, Steenbergen C, Murphy E. Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C. Circ Res 2000, 87(4):309-315.
13. Tong H, Imahashi K, Steenbergen C, Murphy E. Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res 2002, 90(4):377-379. 10.1161/01.RES.0000012567.95445.55, 11884365.
14. Cleveland JC, Meldrum DR, Cain BS, Banerjee A, Harken AH. Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997, 96(1):29-32.
15. Hausenloy DJ, Mwamure PK, Venugopal V, Harris J, Barnard M, Grundy E, Ashley E, Vichare S, Di Salvo C, Kolvekar S, Hayward M, Keogh B, MacAllister RJ, Yellon DM. Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial. Lancet 2007, 370(9587):575-579. 10.1016/S0140-6736(07)61296-3, 17707752.
16. Sullivan PJ, Sweeney KJ, Hirpara KM, Malone CB, Curtin W, Kerin MJ. Cyclical ischaemic preconditioning modulates the adaptive immune response in human limb ischaemia-reperfusion injury. Br J Surg 2009, 96(4):381-390. 10.1002/bjs.6554, 19283744.
17. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
18. Cheung MM, Kharbanda RK, Konstantinov IE, Shimizu M, Frndova H, Li J, Holtby HM, Cox PN, Smallhorn JF, Van Arsdell GS, Redington AN. Randomized controlled trial of the effects of remote ischemic preconditioning on children undergoing cardiac surgery: first clinical application in humans. J Am Coll Cardiol 2006, 47(11):2277-2282. 10.1016/j.jacc.2006.01.066, 16750696.
19. Das DK, Engelman RM, Kimura Y. Molecular adaptation of cellular defences following preconditioning of the heart by repeated ischaemia. Cardiovasc Res 1993, 27(4):578-584. 10.1093/cvr/27.4.578, 8324789.
20. Aebert H, Cornelius T, Ehr T, Holmer SR, Birnbaum DE, Riegger GA, Schunkert H. Expression of immediate early genes after cardioplegic arrest and reperfusion. Ann Thorac Surg 1997, 63(6):1669-1675. 10.1016/S0003-4975(97)00272-5, 9205166.
21. Arab S, Konstantinov IE, Boscarino C, Cukerman E, Mori A, Li J, Liu PP, Redington AN, Coles JG. Early gene expression profiles during intraoperative myocardial ischemia-reperfusion in cardiac surgery. J Thorac Cardiovasc Surg 2007, 134(1):74-81. 81 e71-72., 10.1016/j.jtcvs.2007.01.025, 17599489.
22. Li Q, Bolli R, Qiu Y, Tang XL, Guo Y, French BA. Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation 2001, 103(14):1893-1898.
23. Yamashita N, Nishida M, Hoshida S, Kuzuya T, Hori M, Taniguchi N, Kamada T, Tada M. Induction of manganese superoxide dismutase in rat cardiac myocytes increases tolerance to hypoxia 24 hours after preconditioning. J Clin Invest 1994, 94(6):2193-2199. 10.1172/JCI117580, 330044, 7989574.
24. Jaiswal AK. Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med 2004, 36(10):1199-1207. 10.1016/j.freeradbiomed.2004.02.074, 15110384.
25. Leonard MO, Kieran NE, Howell K, Burne MJ, Varadarajan R, Dhakshinamoorthy S, Porter AG, O'Farrelly C, Rabb H, Taylor CT. Reoxygenation-specific activation of the antioxidant transcription factor Nrf2 mediates cytoprotective gene expression in ischemia-reperfusion injury. Faseb J 2006, 20(14):2624-2626. 10.1096/fj.06-5097fje, 17142801.
26. Calvert JW, Jha S, Gundewar S, Elrod JW, Ramachandran A, Pattillo CB, Kevil CG, Lefer DJ. Hydrogen sulfide mediates cardioprotection through Nrf2 signaling. Circ Res 2009, 105(4):365-374. 10.1161/CIRCRESAHA.109.199919, 19608979.
27. Das DK, Maulik N. Cardiac genomic response following preconditioning stimulus. Cardiovasc Res 2006, 70(2):254-263. 10.1016/j.cardiores.2006.02.023, 16566910.
28. Guisasola MC, Desco Mdel M, Gonzalez FS, Asensio F, Dulin E, Suarez A, Garcia Barreno P. Heat shock proteins, end effectors of myocardium ischemic preconditioning?. Cell Stress Chaperones 2006, 11(3):250-258. 10.1379/CSC-181R1.1, 1576469, 17009598.
29. Efthymiou CA, Mocanu MM, de Belleroche J, Wells DJ, Latchmann DS, Yellon DM. Heat shock protein 27 protects the heart against myocardial infarction. Basic Res Cardiol 2004, 99(6):392-394. 10.1007/s00395-004-0483-6, 15309411.
30. Szabo A, Varga R, Keresztes M, Vizler C, Nemeth I, Razga Z, Boros M. Ischemic limb preconditioning downregulates systemic inflammatory activation. J Orthop Res 2009, 27(7):897-902. 10.1002/jor.20829, 19105227.
31. Kharbanda RK, Peters M, Walton B, Kattenhorn M, Mullen M, Klein N, Vallance P, Deanfield J, MacAllister R. Ischemic preconditioning prevents endothelial injury and systemic neutrophil activation during ischemia-reperfusion in humans in vivo. Circulation 2001, 103(12):1624-1630.
32. Konstantinov IE, Arab S, Kharbanda RK, Li J, Cheung MM, Cherepanov V, Downey GP, Liu PP, Cukerman E, Coles JG, Redington AN. The remote ischemic preconditioning stimulus modifies inflammatory gene expression in humans. Physiol Genomics 2004, 19(1):143-150. 10.1152/physiolgenomics.00046.2004, 15304621.